{
    "root": "cf3405b0-5d45-4bfc-bd77-dd330fe9f04f",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Clobazam",
    "value": "20250110",
    "ingredients": [
        {
            "name": "Clobazam",
            "code": "2MRO291B4U"
        },
        {
            "name": "MAGNESIUM ALUMINUM SILICATE",
            "code": "6M3P64V0NC"
        },
        {
            "name": "XANTHAN GUM",
            "code": "TTV12P4NEE"
        },
        {
            "name": "CITRIC ACID MONOHYDRATE",
            "code": "2968PHW8QP"
        },
        {
            "name": "SODIUM PHOSPHATE, DIBASIC, DIHYDRATE",
            "code": "94255I6E2T"
        },
        {
            "name": "DIMETHICONE",
            "code": "92RU3N3Y1O"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "SUCRALOSE",
            "code": "96K6UQ3ZD4"
        },
        {
            "name": "MALTITOL",
            "code": "D65DG142WK"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        }
    ],
    "indications": "Clobazam oral suspension is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.",
    "contraindications": "For doses above 5 mg/day administer in two divided doses. ( 2.1 ) Patients â‰¤ 30 kg body weight: Initiate at 5 mg daily and titrate as tolerated up to 20 mg daily. ( 2.1 ) Patients > 30 kg body weight: Initiate at 10 mg daily and titrate as tolerated up to 40 mg daily. ( 2.1 ) Dosage adjustment needed in following groups: Geriatric patients ( 2.4 , 8.5 ) Known CYP2C19 poor metabolizers ( 2.5 ) Mild or moderate hepatic impairment; no information for severe hepatic impairment ( 2.7 , 8.8 ) Oral suspension: Can be taken with or without food. ( 2.3 )",
    "warningsAndPrecautions": "Clobazam oral suspension, 2.5 mg/mL, is a berry flavored off-white liquid.Store clobazam oral suspension in an upright position. It is available as follows:\n                  NDC 68094-066-584 ml per unit dose syringeFifty (50) syringes per shipper\n                  NDC 68094-074-584 ml per unit dose ENFit syringeFifty (50) syringes per shipper",
    "adverseReactions": "Clobazam oral suspension is contraindicated in patients with a history of hypersensitivity to the drug or its ingredients. Hypersensitivity reactions have included serious dermatological reactions [see Warnings and Precautions (5.6)]."
}